Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04TMQ
|
||||
Former ID |
DAP001468
|
||||
Drug Name |
D-cycloserine
|
||||
Synonyms |
Cicloserina; Closerin; Closina; Cyclorin; Cycloserine; Cycloserinum; Farmiserina; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamycin; Seromycin; Tebemicina; Tisomycin; Wasserina; Cicloserina [Italian]; Oxamicina [Italian]; C 3909; PA 94; Alpha-Cycloserine; C-9390; C-9400; Cicloserina [INN-Spanish]; Cycloserinum [INN-Latin]; D-CS; DRG-0195; I-1431; K-300; PA-94; SC-49088; Seromycin (TN); Cyclo-D-serine; Cycloserine [INN:BAN:JAN]; E-733-A; RO-1-9213; Cycloserine (JP15/USP/INN); D-amino-3-isoxazolidinone; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; R(+)-4-Amino-3-isoxazolidinone; (+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Eli Lilly
|
||||
Structure |
Download2D MOL |
||||
Formula |
C3H6N2O2
|
||||
Canonical SMILES |
C1C(C(=O)NO1)N
|
||||
InChI |
1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1
|
||||
InChIKey |
DYDCUQKUCUHJBH-UWTATZPHSA-N
|
||||
CAS Number |
CAS 68-41-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10257, 602895, 829389, 841629, 3139717, 7847941, 7885338, 7979010, 8149277, 8153915, 11110913, 11110914, 11110915, 11112194, 11112195, 11335273, 11360512, 11363754, 11366316, 11368878, 11371441, 11374029, 11377040, 11461484, 11467117, 11468237, 11483744, 11486765, 11487900, 11490187, 11492120, 11494674, 12014545, 15170469, 17404815, 24277962, 24858076, 24892907, 24892979, 25622405, 26611680, 26679210, 26719637, 29214856, 29225230, 46386864, 46392863, 46506865, 46507135, 47216632
|
||||
ChEBI ID |
ChEBI:40009
|
||||
SuperDrug ATC ID |
J04AB01
|
||||
SuperDrug CAS ID |
cas=000068417
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | NMDA receptor | Target Info | Agonist | [536773], [536854] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.